Epidermal Growth Factor Receptor (EGFR) and its Cross-Talks with Topoisomerases: Challenges and Opportunities for Multi-Target Anticancer Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|21|3226-3236

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.21, 2016-06, pp. : 3226-3236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal Growth Factor Receptor as a Target: Recent Developments in the Search for Effective New Anti-Cancer Agents

By  

Current Drug Targets, Vol. 2, Iss. 2, 2001-06 ,pp. : 117-133

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond RAS: The Role of Epidermal Growth Factor Receptor (EGFR) and its Network in the Prediction of Clinical Outcome During Anti-EGFR Treatment in Colorectal Cancer Patients

By  

Current Drug Targets, Vol. 15, Iss. 13, 2014-12 ,pp. : 1225-1230

Bentham Science Publishers

Access to resources Recommend Favorite

Downstream intracellular effectors of epidermal growth factor receptor as targets for anticancer therapy

By Milano Amalia   De Rosa Vincenzo   Iaffaioli Rosario Vincenzo   Caponigro Francesco  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 6, 2007-06 ,pp. : 771-782

Informa Healthcare

Access to resources Recommend Favorite

Epidermal growth factor receptor: an important target in esophageal cancer

By Hong Liu   Han Yu   Brain Lubi  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 10, 2013-10 ,pp. : 1179-1185

Informa Healthcare

Access to resources Recommend Favorite

Anti-epidermal growth factor receptor drugs in cancer therapy

By Tortora Giampaolo   Ciardiello Fortunato  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 755-768

Informa Healthcare

Access to resources Recommend Favorite